INR 1.64
(4.46%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 46.89 Million INR | -52.36% |
2022 | 98.42 Million INR | 21.64% |
2021 | 80.92 Million INR | -4.41% |
2020 | 84.65 Million INR | 10.97% |
2019 | 76.28 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 2.35 Million INR | -94.99% |
2024 Q2 | 2.52 Million INR | 7.4% |
2023 Q2 | 52.31 Million INR | 1425.13% |
2023 FY | 46.89 Million INR | -52.36% |
2023 Q4 | 46.89 Million INR | 2173.0% |
2023 Q3 | 2.06 Million INR | -96.06% |
2023 Q1 | 3.43 Million INR | -96.52% |
2022 Q4 | 98.42 Million INR | 7334.21% |
2022 Q2 | 86.74 Million INR | 0.0% |
2022 Q3 | 1.32 Million INR | -98.47% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 114.62 Million INR | 59.091% |
Checkpoint Trends Limited | -137.43 Thousand INR | 34220.643% |
Everest Organics Limited | 569.61 Million INR | 91.768% |
GUJARAT INJECT (KERALA) LTD. | -29.19 Million INR | 260.639% |
NATURO INDIABULL LIMITED | 118.7 Million INR | 60.498% |
NEXUS SURGICAL AND MEDICARE LI | -2.34 Million INR | 2102.729% |
Rama Vision Limited | 184.62 Million INR | 74.602% |
Vivo Bio Tech Limited | 716.74 Million INR | 93.458% |